PRODUCT LITERATURE

Efficacy and safety of ipratropium bromide/ albuterol compared with albuterol in patients with moderate-to-severe asthma: a randomized controlled trial

---

Many patients with asthma require frequent rescue medication for acute symptoms despite appropriate controller therapies. Thus, determining the most effective relief regimen is important in the management of more severe asthma. This study’s objective was to evaluate whether ipratropium bromide/albuterol metered-dose inhaler (CVT-MDI) provides more effective acute relief of bronchospasm in moderate-to-severe asthma than albuterol hydrofluoroalkaline (ALB-HFA) alone after 4 weeks.

---

Availability

Detail Information

Series Title

-

Call Number

-

Publisher

: .,

Collation

-

Language

English

ISBN/ISSN

-

Classification

NONE

Content Type

-

Media Type

-

Carrier Type

-

Edition

-

Subject(s)

Respitor

Specific Detail Info

BMC Pulmonary Medicine (2016) 16:65

Statement of Responsibility

-

Other version/related

File Attachment

Comments

---

You must be logged in to post a comment